Role of oligomers in the amyloidogenesis of primary cutaneous amyloidosis

Journal of the American Academy of Dermatology

Volumn 65, Issue 5, 2011, Pages 1023-1031

  Clos, Audra L ^a   Lasagna Reeves, Cristian A ^a   Kelly, Brent ^a   Wagner, Richard ^a   Wilkerson, Michael ^a   Jackson, George R ^a   Kayed, Rakez ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

amyloid; basal cells; conformational antibodies; oligomers; primary cutaneous amyloidosis; protein misfolding

Indexed keywords

CONGO RED; EOSIN; OLIGOMER; THIOFLAVINE;

AMYLOIDOSIS; ARTICLE; BASAL CELL; BASEMENT MEMBRANE; CLINICAL ARTICLE; DERMIS; DISEASE COURSE; EPIDERMIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LICHENOID; LICHENOID CUTANEOUS AMYLOIDOSIS; MACULAR CUTANEOUS AMYLOIDOSIS; MALE; POLARIZATION MICROSCOPY; PRIMARY CUTANEOUS AMYLOIDOSIS; PRIORITY JOURNAL;

AMYLOIDOGENIC PROTEINS; AMYLOIDOSIS; ANTIBODY SPECIFICITY; BIREFRINGENCE; CELL MEMBRANE; COLORING AGENTS; CONGO RED; DERMIS; EOSINE YELLOWISH-(YS); EPIDERMIS; FEMALE; FIBROBLASTS; HEMATOXYLIN; HUMANS; MACROPHAGES; MALE; MICROSCOPY, POLARIZATION; MODELS, BIOLOGICAL; OLIGOPEPTIDES; PROTEIN CONFORMATION; PROTEIN FOLDING; SKIN DISEASES; STAINING AND LABELING; THIAZOLES;

EID: 80054117502     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.09.735     Document Type: Article

References (46)

1. G. Husby Nomenclature and classification of amyloid and amyloidoses J Intern Med 232 1992 511 512
2. R.A. Kyle, and M.A. Gertz Systemic amyloidosis Crit Rev Oncol Hematol 10 1990 49 87
3. A.S. Cohen Primary (AL) amyloidosis Ren Fail 15 1993 429 433
4. C. Rocken, E.B. Schwotzer, R.P. Linke, and W. Saeger The classification of amyloid deposits in clinicopathological practice Histopathology 29 1996 325 335
5. J.D. Sipe, and A.S. Cohen Review: history of the amyloid fibril J Struct Biol 130 2000 88 98
6. J.I. Guijarro, M. Sunde, J.A. Jones, I.D. Campbell, and C.M. Dobson Amyloid fibril formation by an SH3 domain Proc Natl Acad Sci U S A 95 1998 4224 4228
7. F. Chiti, P. Webster, N. Taddei, A. Clark, M. Stefani, and G. Ramponi Designing conditions for in vitro formation of amyloid protofilaments and fibrils Proc Natl Acad Sci U S A 96 1999 3590 3594
8. M. López De La Paz, K. Goldie, J. Zurdo, E. Lacroix, C.M. Dobson, and A. Hoenger De novo designed peptide-based amyloid fibrils Proc Natl Acad Sci U S A 99 2002 16052 16057
9. M.W. West, W. Wang, J. Patterson, J.D. Mancias, J.R. Beasley, and M.H. Hecht De novo amyloid proteins from designed combinatorial libraries Proc Natl Acad Sci U S A 96 1999 11211 11216
10. M. von Bergen, P. Friedhoff, J. Biernat, J. Heberle, E.M. Mandelkow, and E. Mandelkow Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure Proc Natl Acad Sci U S A 97 2000 5129 5134
11. R. Azriel, and E. Gazit Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide: an experimental support for the key role of the phenylalanine residue in amyloid formation J Biol Chem 276 2001 34156 34161
12. V. Villegas, J. Zurdo, V.V. Filimonov, F.X. Aviles, C.M. Dobson, and L. Serrano Protein engineering as a strategy to avoid formation of amyloid fibrils Protein Sci 9 2000 1700 1708
13. P. Hammarstrom, X. Jiang, A.R. Hurshman, E.T. Powers, and J.W. Kelly Sequence-dependent denaturation energetics: a major determinant in amyloid disease diversity Proc Natl Acad Sci U S A 99 Suppl 4 2002 16427 16432
14. K. Tenidis, M. Waldner, J. Bernhagen, W. Fischle, M. Bergmann, and M. Weber Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties J Mol Biol 295 2000 1055 1071
15. M. López de la Paz, and L. Serrano Sequence determinants of amyloid fibril formation Proc Natl Acad Sci U S A 101 2004 87 92
16. M.G. Botelho, and O. Lupi Protein folding and cutaneous diseases Int J Dermatol 47 2008 1225 1233
17. D.M. Fowler, A.V. Koulov, W.E. Balch, and J.W. Kelly Functional amyloid-from bacteria to humans Trends Biochem Sci 32 2007 217 224
18. F. Chiti, and C.M. Dobson Protein misfolding, functional amyloid, and human disease Annu Rev Biochem 75 2006 333 366
19. D.M. Touart, and P. Sau Cutaneous deposition diseases: part I J Am Acad Dermatol 39 2Pt1 1998 149 171 quiz 72-4
20. M.M. Black The role of the epidermis in the histopathogenesis of lichen amyloidosus: histochemical correlations Br J Dermatol 85 1971 524 530
21. M.M. Black, and E.W. Jones Macular amyloidosis: a study of 21 cases with special reference to the role of the epidermis in its histogenesis Br J Dermatol 84 1971 199 209
22. K. Hashimoto, and M. Kumakiri Colloid-amyloid bodies in PUVA-treated human psoriatic patients J Invest Dermatol 72 1979 70 80
23. K. Hashimoto, and H. Kobayashi Histogenesis of amyloid in the skin Am J Dermatopathol 2 1980 165 171
24. M. Kumakiri, and K. Hashimoto Histogenesis of primary localized cutaneous amyloidosis: sequential change of epidermal keratinocytes to amyloid via filamentous degeneration J Invest Dermatol 73 1979 150 162
25. H. Kobayashi, and K. Hashimoto Amyloidogenesis in organ-limited cutaneous amyloidosis: an antigenic identity between epidermal keratin and skin amyloid J Invest Dermatol 80 1983 66 72
26. H. Eto, K. Hashimoto, H. Kobayashi, T. Fukaya, M. Matsumoto, and T.T. Sun Differential staining of cytoid bodies and skin-limited amyloids with monoclonal anti-keratin antibodies Am J Pathol 116 1984 473 481
27. M. Yanagihara, and S. Mori Histogenesis of macular amyloidosis [in Japanese] Nippon Hifuka Gakkai Zasshi 92 1982 851 859
28. J.T. Jarrett, and P.T. Lansbury Jr. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73 1993 1055 1058
29. J.D. Harper, and P.T. Lansbury Jr. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins Annu Rev Biochem 66 1997 385 407
30. S.J. Wood, J. Wypych, S. Steavenson, J.C. Louis, M. Citron, and A.L. Biere α-Synuclein fibrillogenesis is nucleation-dependent: implications for the pathogenesis of Parkinson's disease J Biol Chem 274 1999 19509 19512
31. G. Bhak, Y.J. Choe, and S.R. Paik Mechanism of amyloidogenesis: nucleation-dependent fibrillation versus double-concerted fibrillation BMB Rep 42 2009 541 551
32. G. Bhak, J.H. Lee, J.S. Hahn, and S.R. Paik Granular assembly of α-synuclein leading to the accelerated amyloid fibril formation with shear stress PLoS One 4 2009 e4177
33. R. Kayed, E. Head, F. Sarsoza, T. Saing, C.W. Cotman, and M. Necula Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers Mol Neurodegener 2 2007 18
34. R. Kayed, E. Head, J.L. Thompson, T.M. McIntire, S.C. Milton, and C.W. Cotman Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 2003 486 489
35. E.M. Sigurdsson Immunotherapy for conformational diseases Curr Pharm Des 12 2006 2569 2585
36. A.L. Clos, C.A. Lasagna-Reeves, R. Wagner, B. Kelly, G.R. Jackson, and R. Kayed Therapeutic removal of amyloid deposits in cutaneous amyloidosis by localised intra-lesional injections of anti-amyloid antibodies Exp Dermatol 19 2010 904 911
37. C.Y. Lin, T. Gurlo, R. Kayed, A.E. Butler, L. Haataja, and C.G. Glabe Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced β-cell apoptosis in h-IAPP transgenic mice Diabetes 56 2007 1324 1332
38. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
39. C.G. Glabe Structural classification of toxic amyloid oligomers J Biol Chem 283 2008 29639 29643
40. M. Kumakiri, K. Hashimoto, I. Tsukinaga, T. Kimura, and Y. Miura Presence of basal lamina-like substance with anchoring fibrils within the amyloid deposits of primary localized cutaneous amyloidosis J Invest Dermatol 81 1983 153 157
41. P. Westermark, K. Lundmark, and G.T. Westermark Fibrils from designed non-amyloid-related synthetic peptides induce AA-amyloidosis during inflammation in an animal model PLoS One 4 2009 e6041
42. M.P. Lambert, A.K. Barlow, B.A. Chromy, C. Edwards, R. Freed, and M. Liosatos Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins Proc Natl Acad Sci U S A 95 1998 6448 6453
43. R.G. Nagele, M.R. D'Andrea, H. Lee, V. Venkataraman, and H.Y. Wang Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains Brain Res 971 2003 197 209
44. P.H. Ren, J.E. Lauckner, I. Kachirskaia, J.E. Heuser, R. Melki, and R.R. Kopito Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates Nat Cell Biol 11 2009 219 225
45. T. Vogiatzi, M. Xilouri, K. Vekrellis, and L. Stefanis Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells J Biol Chem 283 2008 23542 23556
46. A.C. Magalhaes, G.S. Baron, K.S. Lee, O. Steele-Mortimer, D. Dorward, and M.A. Prado Uptake and neuritic transport of scrapie prion protein coincident with infection of neuronal cells J Neurosci 25 2005 5207 5216